Israpafant T27638
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Israpafant is a selective antagonist for the platelet-activating factor receptor ( IC50 = 0.84nM). Israpafant inhibits PAF-induced human platelet aggregation. Israpafant inhibits the activation of eosinophil cells and consequently delays the development o
CAS nr:
117279-73-9
Purity:
98%
Molecular Weight:
489,08
SMILES:
CC1=NN=C2N1C3=C(C=C(CCC4=CC=C(CC(C)C)C=C4)S3)C(C5=CC=CC=C5Cl)=NC2C
Formula:
C28H29ClN4S
Pathway:
Target:
